MedTrace Logo

Lung Ultrasound for Prediction of Bronchopulmonary Dysplasia

NCT04756297 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 152

Last updated 2021-04-01

No results posted yet for this study

Summary

Extreme preterm infants (GA ≤ 28+6 weeks) are at high risk for bronchopulmonary dysplasia (BPD) that has been associated with significant long-term impairment. Lung ultrasound score (LUSs) has the potential to early identify infants at high risk of developing BPD who may benefit from early intervention.

Aim: To assess if LUS score can be utilized to predict the development of BPD in infants born at ≤ 28+6 weeks, early in their postnatal course, when the disease is likely to be most amenable to therapeutic intervention.

Conditions

  • Bronchopulmonary Dysplasia (BPD)

Sponsors & Collaborators

  • Mount Sinai Hospital, Canada

    collaborator OTHER

  • Health Sciences Centre, Winnipeg, Manitoba

    collaborator OTHER

  • Adel Mohamed

    lead OTHER

Principal Investigators

  • Prakesh Shah, MD · Mount Sinai Hospital- Toronto, ON, Canada

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-01
Primary Completion
2021-02-25
Completion
2021-02-25

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04756297 on ClinicalTrials.gov